
Accendra Health Inc.
ACH | NYSE
$0.89
$0 (+0.03%)
Sep 21, 2026, 12:46 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.76B | 10.7B | 10.33B | 9.96B | 9.79B | 8.48B |
Cost of Revenue | 1.47B | 8.48B | 8.21B | 8.13B | 8.27B | 7.2B |
Gross Profit | 1.29B | 2.22B | 2.13B | 1.83B | 1.51B | 1.28B |
Operating Income | 221.74M | -207.77M | 104.51M | 142.91M | 368.47M | 204.12M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -101.95M | -357.36M | -54.73M | 10.89M | 276.75M | 109.91M |
Net Income | -1.1B | -362.69M | -41.3M | 22.39M | 221.59M | 29.87M |
Selling & General & Admin | 1.07B | 1.91B | 1.81B | 1.55B | 1.08B | 1.04B |
Research & Development | n/a | n/a | n/a | n/a | 12.1M | n/a |
Other Expenses | n/a | 517.13M | 207.09M | 128.62M | 55.59M | 34.05M |
Operating Expenses | 1.07B | 2.43B | 2.02B | 1.68B | 1.14B | 1.08B |
Interest Expense | 107.18M | 143.8M | 157.92M | 128.89M | 48.09M | 83.4M |
Selling & Marketing Expenses | n/a | 17.85K | n/a | n/a | n/a | 389M |
Cost & Expenses | 2.54B | 10.91B | 10.23B | 9.81B | 9.42B | 8.28B |
Income Tax Expense | 729K | 5.33M | -13.43M | -11.5M | 55.17M | 21.83M |
Shares Outstanding (Basic) | 76.9M | 76.74M | 75.79M | 74.5M | 72.74M | 63.37M |
Shares Outstanding (Diluted) | 76.9M | 76.74M | 75.79M | 76.22M | 75.49M | 63.51M |
EPS (Basic) | -14.31 | -4.73 | -0.54 | 0.30 | 3.05 | 0.47 |
EPS (Diluted) | -14.31 | -4.73 | -0.54 | 0.29 | 2.94 | 0.47 |
EBITDA | 219.75M | 51.22M | 390.57M | 368.45M | 415.47M | 323.41M |
EBIT | 5.23M | -213.55M | 103.19M | 139.78M | 324.84M | 240.28M |
Depreciation & Amortization | 214.52M | 264.78M | 287.38M | 228.67M | 90.62M | 83.14M |
Add to Watchlist
Select watchlists to add or remove ACH